NCT06852365View on ClinicalTrials.gov

Combined Oral Contraceptive Pill and Resistance Starch

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 10, 2025

Primary Completion Date

April 30, 2028

Study Completion Date

April 30, 2028

Conditions
Metabolic SyndromePolycystic Ovary Syndrome
Interventions
DIETARY_SUPPLEMENT

wheat dextrin

participants will take 15 grams per day for 12 weeks

DRUG

Oral Contraceptives, Low-Dose

20 micrograms ethinyl estradiol and desogestrel 0.15mg

DIETARY_SUPPLEMENT

Maltodextrin

participants will take 15 grams per day for 12 weeks

Trial Locations (1)

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Pennsylvania

OTHER